Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azathioprine Addition to Anti-TNF Switch in IBD
NCT03580876Phase 4Unknown
- Start
- Jul 2018
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of azathioprine in inflammatory bowel disease (IBD). Status: unknown.
02
Drugs
azathioprine
03
Conditions
inflammatory bowel disease (IBD)
Beyond the preview
Go deeper on NCT03580876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03580876.